Trending...
- Merit Securities Assisted Cre8tive Technology and Design in their Acquisition of EpiCenter ERP - 262
- Saucony® Announces 11 New Athletes to its 2025 North American Roster of Professional Runners
- Gas vs Electric Vehicle: All Costs Compared
SAN FRANCISCO - Californer -- The National Institutes of Health (NIH) has announced a significant reduction in grant allocations for indirect costs, a move that could upend financial stability for research institutions nationwide.
In the 2023 fiscal year alone, the NIH awarded more than $35 billion in funding to nearly 50,000 research projects across over 2,500 universities, medical schools, and institutions. These grants, which supported over 300,000 researchers, played a critical role in advancing medical and scientific breakthroughs.
However, as of Monday, a drastic policy shift will cap indirect funding at 15 percent, down from an average of nearly 30 percent, with some institutions previously receiving overhead allocations exceeding 60 percent. The cuts are expected to save the NIH approximately $4 billion annually but leave universities scrambling to bridge the funding gap.
More on The Californer
The NIH is the world's largest public funder of biomedical and health research, playing a pivotal role in the discovery of treatments, vaccines, and innovative healthcare solutions. The organization directs funding into critical areas such as cancer research, infectious disease prevention, neuroscience, and genomics, among many others. These investments have led to life-saving advancements, including the rapid development of COVID-19 vaccines, the discovery of groundbreaking cancer immunotherapies, and innovative treatments for chronic diseases like diabetes and Alzheimer's.
Throughout its history, NIH-backed research has had profound public health impacts. For instance, the agency's funding helped support the Human Genome Project, which revolutionized personalized medicine. NIH grants were also instrumental in pioneering antiretroviral therapies for HIV/AIDS, effectively transforming the disease from a death sentence into a manageable condition. The institution has consistently played a leading role in addressing global health crises, including the 2014 Ebola outbreak and the COVID-19 pandemic, with its research leading to life-saving vaccines and therapeutic interventions.
More on The Californer
For many research institutions, indirect costs—also referred to as Facilities and Administrative (F&A) costs—are a fundamental component of their NIH grants. These funds cover essential operational expenses, including laboratory maintenance, research compliance, security, and administrative support. Without these resources, universities must either divert funds from other sources or reduce research capacity.
https://www.investorhire.com/news/healthcare-and-economic-impact/healthcare-costs-and-insurance-markets/nih-slashes-research-funding-february-8-2025
In the 2023 fiscal year alone, the NIH awarded more than $35 billion in funding to nearly 50,000 research projects across over 2,500 universities, medical schools, and institutions. These grants, which supported over 300,000 researchers, played a critical role in advancing medical and scientific breakthroughs.
However, as of Monday, a drastic policy shift will cap indirect funding at 15 percent, down from an average of nearly 30 percent, with some institutions previously receiving overhead allocations exceeding 60 percent. The cuts are expected to save the NIH approximately $4 billion annually but leave universities scrambling to bridge the funding gap.
More on The Californer
- The ONE Cold Calling Hack That Will DOUBLE Your Sales Overnight!
- Skyworks Solutions, Inc. (SWKS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- FNL Network Talk Show Wins Prestigious 16th Annual TASTE AWARD
- The OpenSSL Corporation and The OpenSSL Foundation Announce the Formation of Technical Advisory Committees (TACs)
- Com2uS Platform Selected as AWS ISV Accelerate Partner
The NIH is the world's largest public funder of biomedical and health research, playing a pivotal role in the discovery of treatments, vaccines, and innovative healthcare solutions. The organization directs funding into critical areas such as cancer research, infectious disease prevention, neuroscience, and genomics, among many others. These investments have led to life-saving advancements, including the rapid development of COVID-19 vaccines, the discovery of groundbreaking cancer immunotherapies, and innovative treatments for chronic diseases like diabetes and Alzheimer's.
Throughout its history, NIH-backed research has had profound public health impacts. For instance, the agency's funding helped support the Human Genome Project, which revolutionized personalized medicine. NIH grants were also instrumental in pioneering antiretroviral therapies for HIV/AIDS, effectively transforming the disease from a death sentence into a manageable condition. The institution has consistently played a leading role in addressing global health crises, including the 2014 Ebola outbreak and the COVID-19 pandemic, with its research leading to life-saving vaccines and therapeutic interventions.
More on The Californer
- A.N. Publishing Unveils The 2025 'A Hot Set' Media Kit
- Sip, Savor, and Celebrate Earth Day on the Shawangunk Wine Trail - April 26-27, 2025
- Long Beach Temporarily Closes Open Swimming Areas Along Coastal Beaches Due to Sewage Spill
- Caruso Construction Services Expands Premium Remodeling Services in California
- California: Governor Newsom announces appointments 3.13.25
For many research institutions, indirect costs—also referred to as Facilities and Administrative (F&A) costs—are a fundamental component of their NIH grants. These funds cover essential operational expenses, including laboratory maintenance, research compliance, security, and administrative support. Without these resources, universities must either divert funds from other sources or reduce research capacity.
https://www.investorhire.com/news/healthcare-and-economic-impact/healthcare-costs-and-insurance-markets/nih-slashes-research-funding-february-8-2025
Source: Invest or Hire
Filed Under: Media
0 Comments
Latest on The Californer
- Liquid Technologies Announces the Launch of Liquid Studio v21 and Liquid XML Data Binder v21
- Qrybut Successfully Obtains SEC Certification, Bridging Traditional Finance and Digital Assets
- Glisn Launches Revolutionary Cognitive Training App to Combat the Modern Attention Crisis
- Knowledge + Wisdom = Understanding annonces movie And God Will Rise
- Portland's Evolve & Unite Festival Brings a Transformational Experience to the Pacific Northwest
- Tanktwo Launches Cable-less Stackable Battery Solution
- School Launches 250 Students International Service Trips - Gives $1M to Global Education
- StealMyTesla.com: Discreet Tesla Acquisition for Reluctant Owners
- Governor Newsom urges caution and preparedness as storm impacts much of California
- City of Long Beach Hosts Sixth Annual Celebration of the Young Child
- Two of Rare's Critically Acclaimed Games will Return to Home Consoles in 2025
- Merit Securities Assisted Cre8tive Technology and Design in their Acquisition of EpiCenter ERP
- UNITED AIRLINES TEAMSTERS TO RALLY AT SAN FRANCISCO HUB
- ICYMI: California is home to 32 of the top 50 AI companies
- District Court Central District Of California Jonathon Ramos Vs Elizabeth Singleton, El Al
- RAW Artists Announces CEO Transition as the Organization Celebrates Its 16th Anniversary
- City of Long Beach Preparing for Upcoming Weather Event, Urges Residents to Take Precautions
- One Stop Truck & Equipment Expands Work Truck Offerings with Fully Outfitted Fleet Solutions
- Hyundai and Children's Hospital Los Angeles Continue Partnership to Improve Child Passenger and Pedestrian Safety
- UEL Esports Launches Nationwide Tour and Hosts AFV at GDC 2025